Anti-tumor Necrosis Factor Drug Concentration Is Not Associated with Disease Outcomes in Pouchitis: A Retrospective, International Study.

Fiche publication

Date publication

janvier 2025

Journal

Digestive diseases and sciences

Auteurs

Membres identifiés du Cancéropôle Est :
Pr PEYRIN-BIROULET Laurent

Tous les auteurs :
Honap S, Caron B, Ollech JE, Fischman M, Papamichael K, De Jong D, Gecse KB, Centritto A, Samaan MA, Irving PM, Sparrow MP, Karmiris K, Chateau T, Dotan I, Peyrin-Biroulet L,

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/39869163

Résumé

Therapeutic drug monitoring is important for optimizing anti-tumor necrosis factor-α (TNF-α) therapy in inflammatory bowel disease. However, the exposure-response relationship has never been assessed in pouchitis.